|
STK3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.32478489184496E-12 |
| Normal-vs-Stage2 |
1.563050E-03 |
| Normal-vs-Stage3 |
1.41442413337245E-13 |
| Normal-vs-Stage4 |
2.52153853352866E-12 |
| Stage1-vs-Stage2 |
1.275590E-01 |
| Stage1-vs-Stage3 |
1.713560E-01 |
| Stage1-vs-Stage4 |
2.330800E-01 |
| Stage2-vs-Stage3 |
3.757600E-02 |
| Stage2-vs-Stage4 |
4.701700E-02 |
| Stage3-vs-Stage4 |
8.946000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62503344114384E-12 |
| Normal-vs-AfricanAmerican |
1.50568446599664E-12 |
| Normal-vs-Asian |
4.917500E-03 |
| Caucasian-vs-AfricanAmerican |
2.820400E-01 |
| Caucasian-vs-Asian |
9.478400E-01 |
| AfricanAmerican-vs-Asian |
7.324600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
4.54924986570404E-12 |
| Male-vs-Female |
1.661560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.41969810644127E-11 |
| Normal-vs-Age(41-60Yrs) |
6.02662364457274E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
2.33169999999117E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.804200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.509180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.563400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.665600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.103200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.371400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.319300E-03 |
| Normal-vs-Grade 2 |
3.42800010599831E-10 |
| Normal-vs-Grade 3 |
1.65756297576536E-12 |
| Normal-vs-Grade 4 |
1.50990331349021E-14 |
| Grade 1-vs-Grade 2 |
6.120200E-01 |
| Grade 1-vs-Grade 3 |
5.987600E-02 |
| Grade 1-vs-Grade 4 |
2.618000E-02 |
| Grade 2-vs-Grade 3 |
1.665990E-02 |
| Grade 2-vs-Grade 4 |
3.984700E-03 |
| Grade 3-vs-Grade 4 |
2.392800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.94233518158171E-12 |
| Normal-vs-ccB subtype |
5.78269987450142E-10 |
| ccA subtype-vs-ccB subtype |
9.190800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.85369497529564E-11 |
| Normal-vs-N1 |
3.8983000000048E-05 |
| N0-vs-N1 |
4.475400E-01 |
|
|
